Our expertise helps investors assess their opportunities and risks.
Medical & Scientific Briefings
Comprehensive briefings on the medical and scientific background of investment cases
Medical and scientific due diligence
Based on our experience in biomedical research, we can tell you what’s possible today, tomorrow or never.
We make sure investment cases follow current best practices and national / international guidelines
Methods in which we have first-hand experience
qPCR / PCR / RT-PCR
Nucleic acids and gene expression
Electrophoresis and Blotting
Polyacrylamide and agarose gel electrophoresis
Cell cycle analysis, viability, apoptosis, ploidy, kinetics, extracellular and intracellular protein expression, multidrug resistance, etc.
Live and time-lapse microscopy incl. functional (immuno-) fluorescence assays
Primary and established cell lines, monolayer-, co-culture and 3D spheroids
Western Blot (detection with AP & ECL), immunohistochemistry, protein microarrays, chromatin immunoprecipitation (ChIP)
Fluorescence activated cell sorting (FACS)
Genetically engineered animal tumor models, orthotopic tumor models, xenografts, etc.
Trypan blue, MTT, impedance based methods (e.g. xCELLigence by Roche)
Nucleic acid and protein isolation
From whole cells or cellular compartments, or through micro-dissection
Gene knock-down & overexpression
siRNA, shRNA, plasmid DNA vectors